In some cases, your healthcare provider may recommend adjusting the dose of Tirzepatide
Why Choose PlexusDx for HSA-Eligible GLP-1 Therapy PlexusDx combines transparent, flat monthly pricing with HSA and FSA eligibility to simplify weight loss therapy
median BMI at GLP-1 RA initiation was 34 (range, 23-50)
Only 1.6% of participants discontinued due to nausea, meaning the vast majority found it manageable over time (Wilding et al., NEJM 2021)
However, it is even earlier in development than survodutide, with Phase 3 trials ongoing
Minor contour issues often respond well to non-surgical treatments like radiofrequency skin tightening , lymphatic drainage massage , and compression garments , which help improve appearance but may not reduce fat volume